BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2000
View Archived Issues
Enzo Biochem reports significant progress for HIV gene medicine
Read More
Scotia reports improved complete tumor response rate with Foscan PDT
Read More
Novogen anticancer drug advances to phase Ib
Read More
Health Canada grants priority review to Prevnar
Read More
Onyx commences phase III clinical trial of CI-1042 to treat H&N cancer
Read More
Phase II cumulative-dose trial of MSI-albuterol in adults successfully completed
Read More
Icos and Texas Biotechnology enter joint venture to develop and commercialize endothelin antagonists
Read More
In vitro data support continued testing of AIDS vaccine in S. Africa
Read More
CLX-1100: a novel antiinflammatory agent produced by a Himalayan plant
Read More
Centaur describes new nitrone with potential in MS at Immunology 2000
Read More
VX-497: in vitro and in vivo findings on a selective, orally active IMPDH inhibitor
Read More
Further validation of NitroMed's approach to new drug candidates for GI diseases
Read More
ARGENT + Dimerizer Drugs results in sustained production of EPO in monkeys
Read More
Glaxo Wellcome's GI-262570 a success story, ADA participants told
Read More
Development of new formulation of erythropoietin halted
Read More
OSI crosslicenses gene transcription patent estate with Merck
Read More
GenStar's new Ad vector for hemophilia A proves safe and effective in murine model
Read More
News from ADA: Calyx completes phase Ib testing of plant extract
Read More
Axcan completes acquisition of worldwide Photofrin rights
Read More
Methods of diagnosing and treating breast cancer under scrutiny at Georgetown
Read More
U.S. scientists modify RNase A polypeptides to obtain selective cytotoxicity against KS cells
Read More
Cytokine production inhibitors described in patent literature by Novartis
Read More
PDE4-inhibitory respiratory therapeutics designed at Zambon
Read More
Recently issued patent covers potent and selective alpha1A-adrenoceptor antagonists from Merck
Read More
Japanese researchers discover new antiinflammatory substance
Read More
New GI therapeutics in development at Byk Gulden
Read More
BMS presents new IMP dehydrogenase inhibitors
Read More
Preparation and use of new thiazole antitumor agents acting on cdk/cyclin complexes
Read More
New long-acting basal insulin is at least as effective as NPH insulin, with less hypoglycemia
Read More